X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Acta Pharmaceutica Sinica B

期刊標題檢索 ACTA PHARM SIN 最新評論: Are you still in WE now? (2024-12-20)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Acta Pharmaceutica Sinica B]您好,您是該頁面的第 243805 位訪客。

期刊簡介
期刊名稱Acta Pharmaceutica Sinica B Acta Pharmaceutica Sinica B
LetPub Score
8.3
51 ratings
Rate

Reputation
8.9

Influence
7.6

Speed
8.7

期刊簡稱ACTA PHARM SIN B
ISSN2211-3835
E-ISSN2211-3843
h-index28
CiteScore
CiteScoreSJRSNIPCiteScore Rank
22.403.0352.253
Subject fieldQuartilesRankPercentile
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: General Pharmacology, Toxicology and Pharmaceutics
Q11 / 80

自引率 (2023-2024)6.10%自引率趨勢
掲載範囲
The Journal of the Institute of Materia Medica, the Chinese Academy of Medical Sciences and the Chinese Pharmaceutical Association
Peer Review under the responsibility of Institute of Materia Medica, Chinese Academy of Medical Sciences and Chinese Pharmaceutical Association

Acta Pharmaceutica Sinica B (APSB) is a monthly journal, in English, which publishes significant original research articles, rapid communications and high quality reviews of recent advances in all areas of pharmaceutical sciences including pharmacology, pharmaceutics, medicinal chemistry, natural products, pharmacognosy, pharmaceutical analysis and pharmacokinetics.

APSB is a series of journal of Acta Pharmaceutica Sinica, which was founded in 1953, indexed in Chemical Abstracts, Index Medicus, SciFinder Scholar, Biological Abstracts, International Pharmaceutical Abstracts, Cambridge Scientific Abstracts, Current Bibliography on Science and Technology, etc. It sponsored by Insititute of Materia Medica, Chineses Acedemy of Medical Sciences and Chinese Pharmaceutical Association, production and hosting by Elsevier B.V.
官方網站https://www.sciencedirect.com/journal/acta-pharmaceutica-sinica-b
在線稿件提交https://www.editorialmanager.com/apsb/default.aspx
開放訪問Yes
出版商Elsevier BV
主題領域Pharmacology, Toxicology and Pharmaceutics
出版國/地區CHINA MAINLAND
發行頻率月刊
創刊年2011
每年文章數300每年文章數趨勢
黃金OA百分比98.22%
OA Related Info
APC: Yes( Full Length Articles and Reviews - USD2600; Short Articles - USD2000; )
APC waiver:Check Notes
Other charges: No
Keywords: pharmaceutical science、traditional chinese medicine、pharmaceutics、pharmaceutical chemistry、pharmacokinetics
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
PHARMACOLOGY & PHARMACYSCIEQ15/354
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2211-3835%5BISSN%5D
平均審稿時間 *來自出版商的數據: Submission to first decision: 8 days; Review time: 36 days; Submission to Accept: 134 days; Acceptance to publication: 7 days;
來自作者的數據: 19 Weeks
競爭力 *來自作者的數據:
來自Elsevier的數據: 9%
參考鏈接
相關期刊 【Acta Pharmaceutica Sinica B】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Antibiotics-BaselH-index: 0

    CiteScore: 7.30
    Pharmacology Research & PerspectivesH-index: 0

    CiteScore: 5.30
    Therapeutics and Clinical Risk ManagementH-index: 0

    CiteScore: 5.30
    Revista Brasileira de Farmacognosia-Brazilian Journal of PharmacognosyH-index: 37

    CiteScore: 2.60
    Infarma Pharmaceutical SciencesH-index: 0

    CiteScore: 0.10
    Mental Health ClinicianH-index: 0

    CiteScore: 1.90
    Pharmacological Research Modern Chinese MedicineH-index: 0

    CiteScore: 1.60
    學科內最受檢索的期刊 頁面查看次數
    Antibiotics-Basel34002
    Revista Brasileira de Farmacognosia-Brazilian Journal of Pharmacognosy21777
    Pharmacology Research & Perspectives17633
    Therapeutics and Clinical Risk Management6672
    Pharmacological Research Modern Chinese Medicine2156
    Infarma Pharmaceutical Sciences2032
    Mental Health Clinician864
  •  

    Acta Pharmaceutica Sinica B Acta Pharmaceutica Sinica B
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/9)
  [Acta Pharmaceutica Sinica B] 的評論撰寫評論
作者: 哈哈哈


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-12-20 12:37:04 評論於
Are you still in WE now?
(0) 讚! | 哈哈哈

作者: qty


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-11-29 14:58:44 評論於
It has been 10 days with the editor.
(0) 讚! | qty

作者: asd3204


領域: 医学
審稿時間: 5.0 month(s)
結果: 修改後接受


撰寫評論

2024-11-07 22:47:41 評論於
You can submit something else, no problem. Anything sent directly to the editor after the deadline will be rejected, without exception.
(0) 讚! | asd3204

作者: Tan-Xin


領域: 材料科学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-11-03 16:24:21 評論於
After submission, it was with the editor. Then it was DIP. Does this mean it has been rejected, and can I prepare to submit to other journals?
(0) 讚! | Tan-Xin

作者: 一条小春豪


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-19 21:00:44 評論於
Friend, has your status changed? I am also DIP now.
(0) 讚! | 一条小春豪

作者: 龙鳞新峰


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-15 16:56:02 評論於
Please translate the following passage into English: None
(0) 讚! | 龙鳞新峰

作者: 辉666


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-12 10:18:37 評論於
How long does the with editor stage last?
(1) 讚! | 辉666

作者: 暗月寺乐安


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-11 20:37:11 評論於
Do they need a full wrap for their WB?
(0) 讚! | 暗月寺乐安

作者: accept !!!


領域: 生物学
審稿時間: 4.0 month(s)
結果: 拒稿


撰寫評論

2024-10-10 18:14:51 評論於
It took them 3 months and 10 days to reject me, it hurts, it's too slow, okay?
(0) 讚! | accept !!!

作者: 桂枝小郎君


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-09 19:29:50 評論於
May I ask what is going on behind?
(0) 讚! | 桂枝小郎君

作者: 桂枝小郎君


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-09 19:24:49 評論於
How did it go later on?
(0) 讚! | 桂枝小郎君

作者: 桂枝小郎君


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-09 19:24:31 評論於
May I ask what happened afterwards?
(0) 讚! | 桂枝小郎君

作者: 桂枝小郎君


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-09 15:33:12 評論於
Review speed: 24.0 | Submission hit rate: 5.0 Experience sharing: so slow
(0) 讚! | 桂枝小郎君

作者: 念香Sama


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-25 19:31:57 評論於
I submitted on 9.25 and the next day on 9.26, it was already in the decision in process status. Does this mean that I will be rejected and there is no possibility of being under review again?
(0) 讚! | 念香Sama

作者: Adelaide Lawson


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-25 13:51:13 評論於
What is the current status of the manuscript? Requesting an update on the status.
(0) 讚! | Adelaide Lawson

作者: 蒙德锦玉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-23 19:40:51 評論於
Have you received it? I have been pre-accepted for over a month and have been with the editor the whole time.
(0) 讚! | 蒙德锦玉

作者: 风陵齐心


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-30 16:08:11 評論於
May I ask how things are going?
(0) 讚! | 风陵齐心

作者: 只求能毕业--


領域: 医学
審稿時間: 9.0 month(s)
結果: 修改後接受


撰寫評論

2024-08-25 09:17:42 評論於
After half a year of waiting, I finally got accepted. After so many years of studying, I finally got a top publication half a year after graduation. I hope the journal will continue to improve! I hope my application for the Youth Fund next year will have a good result!
(0) 讚! | 只求能毕业--

作者: 尤金杰克


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-24 18:12:30 評論於
No translation needed.
(0) 讚! | 尤金杰克

作者: 一条小冬荷


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-17 21:40:32 評論於
Can I ask if you have got the results back?
(0) 讚! | 一条小冬荷

作者: 削月欣怿


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-16 14:16:53 評論於
Review speed: 6.0 | Submission acceptance rate: 50.0
Experience sharing: Can someone please explain why the publication is not allowing me to pay the page fees? I have sent several reminder emails, but they keep telling me to wait. Has anyone else experienced this before?
(0) 讚! | 削月欣怿

作者: 咏春顺慈


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-12 20:58:34 評論於
It has been reviewed for the third time, under review for a month, and then another two weeks for the dip. Is the editorial department on vacation? It shouldn't be this slow.
(0) 讚! | 咏春顺慈

作者: 尤金杰克


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-07 09:53:13 評論於
Review speed: 2.0 | Submission success rate: 25.0 Experience sharing: under review for a month.
(0) 讚! | 尤金杰克

作者: Adelaide Lawson


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-07-24 22:28:44 評論於
It generally takes several months to go from proof to online, ranging from a few days to a few weeks.
(0) 讚! | Adelaide Lawson

作者: 风陵齐心


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-07-18 10:12:36 評論於
How are you doing?
(0) 讚! | 风陵齐心

首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/9)

開始撰寫 [Acta Pharmaceutica Sinica B] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*